Visage Imaging Releases Its New 5.3 Amira

Visage Imaging, Inc., a branch of Pro Medicus Ltd., announced that it has released its new 5.3 version of Amira, a platform for visualizing, analyzing, and presenting complex 3D and 4D biomedical data. Amira has new Neuro option that includes several comprehensive tools for neuroscience research, such as MR diffusion tensor imaging (DTI), in addition to CT and MR brain perfusion imaging. The new version of Amira offers efficient calculation of perfusion results along with analysis and display of multi-channel functional image data such as gradients, tensors, and fiber tracking.

http://www.healthimaginghub.com/article/1599-visage-imaging-releases-its-new-53-amira.html

IVF Children Have Higher Risk for Cancer, Study

According to a recent study, children conceived by in vitro fertilization (IVF) are subjected to higher risks of having cancer more than their natural conceived counterparts. The results were highlighted in the journal Pediatrics.

http://www.healthimaginghub.com/article/1598-ivf-children-have-higher-risk-for-cancer-study.html

A Journey For Brain Cancer Has Been Completed

Anne Feeley has recently completed a journey throughout the United States in order to raise awareness and funds for brain cancer research. Feeley is a brain cancer survivor and a 56 years old mother. She covered a distance of 3,708 miles while cycling; her last 6.5 miles were cycled from Hains Point, VA to the finishing line at the Capital Reflecting Pool in Washington, DC.

http://www.healthimaginghub.com/article/1596-a-journey-for-brain-cancer-has-been-completed.html

Different Methods Recently Tested For Measuring Breast Density

Three different methods for measuring breast density accurately - through the relative portion of tissue to fat in a woman's breasts and a strong indicator of breast cancer risk- have been tested this week according to two new studies. The two studies were conducted by a group of medical physicists at the University of California, Irvine, led by Sabee Molloi, and both will be presented today and tomorrow at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, PA.

http://www.healthimaginghub.com/article/1595-three-different-methods-recently-tested-to-measure-breast-density-accurately.html

Fund Awarded To Four Breast Cancer Researchers

Susan G. Komen for the Cure® has recently granted a total fund of $1.2 million to four breast cancer researchers from Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) in Detroit, Michigan. The fund is granted in order to help researchers to go on with their studies for new ways to diagnose, prevent and control breast cancer. The $1.2 million is a part of a larger $59 million grants the Susan G. Komen for the Cure® has awarded this year to support breast cancer researches.

http://www.healthimaginghub.com/article/1594-fund-awarded-to-four-breast-cancer-researchers.html

Advanced RapidArc Radiotherapy Treatments Is Now Available for Cancer Patients In Scotland

Four head & neck cancer patients have been treated to date at the Beatson West of Scotland Cancer Centre in Glasgow by the fast and efficient RapidArc® technology from Varian Medical Systems, in which one of the UK's largest radiotherapy departments has begun treatments using it."This is a significant advance for one of the busiest cancer centers in the country and provides an opportunity to offer advanced IMRT treatments to more patients," says David Dodds, clinical lead for radiotherapy. "In the past the provision for IMRT has been limited as this sophisticated technique typically takes longer to deliver. RapidArc will allow us to treat much more quickly and as a result more patients will be able to benefit from the technology."

http://www.healthimaginghub.com/article/1593-advanced-rapidarc-radiotherapy-treatments-is-now-available-for-cancer-patients-in-scotland.html

Lantheus To Provide DEFINITY In India

Lantheus Medical Imaging, Inc., a leading company offering diagnostic imaging solutions, announced that it has provided its DEFINITY® Vial, an ultrasound contrast imaging agent, in the market in India. Lantheus has closed a deal with J.B. Chemicals & Pharmaceuticals, Ltd. (JBCPL), a major company located in Mumbai,to distribute and market DEFINITY in India. DEFINITY, a Perflutren Lipid Microsphere ultrasound contrast agent, is already available in markets of Australia, New Zealand in addition to North America and several countries in the Middle East. In India, DEFINITY®  is indicated for patients with suboptimal echocardiograms, as it opacifys the left ventricle in addition to enhancing the delineation of the left ventricular endocardial border, it can also be sued in patients for contrast-enhanced diagnostic ultrasound imaging for better reviewing of focal lesions of the kidney and liver.

http://www.healthimaginghub.com/article/1592-lantheus-to-provide-definity-in-india.html

FIDI Acquires New PACS And EMR Systems From PACSGEAR

Fundação Instituto de Pesquisa e Estudo de Diagnóstico por Imagem (FIDI) located in Sao Paolo, Brazil, announced that it has recently acquired a new PACS and Electronic Medical Record (EMR) solution, in order to improve the quality of the provided healthcare services in the facility.

http://www.healthimaginghub.com/article/1591-fidi-acquires-new-pacs-and-emr-systems-from-pacsgear.html